In brief, it revealed that GSTM1 null, GSTT1 null and GSTP1-Val genotypes were appreciably associated with augmented risk of NAFLD vulnerability. The gene discussed is GSTP1; the disease is metabolic dysfunction-associated steatotic liver disease.